CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Reconciliation of net income (loss) to cash provided by operating activities:
Net income (loss)	$ 6,009	$ (9,064)
Add (deduct):
Depreciation and amortization	6,378	8,306
Provision for bad debt	366	711
Investment and other gains – net	(287)	(488)
Amortization of net premium on investments available-for-sale	1,718	1,742
Payments for title losses in excess of provisions	(3,605)	(523)
Adjustment for insurance recoveries of title losses	409	312
Increase in receivables – net	(3,896)	(3,622)
Increase in other assets – net	(666)	(2,583)
Decrease in payables and accrued liabilities – net	(27,355)	(26,540)
Change in net deferred income taxes	136	(1,953)
Net income from equity investees	(197)	(341)
Dividends received from equity investees	570	581
Stock based compensation expense	1,230	1,395
Other – net	1	226
Cash used by operating activities	(19,189)	(31,841)
Investing activities:
Proceeds from investments available-for-sale sold	15,843	11,327
Proceeds from investments available-for-sale matured	14,956	260
Purchases of investments available-for-sale	(51,981)	(44,254)
Net purchases of short-term investments	(597)	(2,302)
Purchases of property and equipment, title plants and real estate – net	(5,586)	(5,494)
Other – net	449	387
Cash used by investing activities	(26,916)	(40,076)
Financing activities:
Payments on notes payable	(8,382)	(1,307)
Proceeds from notes payable	875	10,000
Distributions to noncontrolling interests	(2,563)	(3,028)
Cash dividends paid	(7,031)	(6,720)
Other – net	(818)	(240)
Cash used by financing activities	(17,919)	(1,295)
Effects of changes in foreign currency exchange rates	827	2,898
Decrease in cash and cash equivalents	(63,197)	(70,314)
Cash and cash equivalents at beginning of period	185,772	179,067
Cash and cash equivalents at end of period	$ 122,575	$ 108,753